Natural course of mild Graves' orbitopathy: is it a chronic remitting or a transient disease?
OBJECTIVE
The natural course of Graves' orbitopathy (GO) has been poorly documented. The aim of this review is to provide current knowledge regarding the natural course of mild GO, trying to address the issue of whether and to what extent it constitutes a chronic remitting or transient disease.


METHODS
We systematically searched PubMed for English language publications until August 2016 under the following terms: "Graves' orbitopathy" OR "Graves' ophthalmopathy" OR "thyroid eye disease" AND "natural course" OR "natural history".


RESULTS
Few studies have investigated the course of mild orbital disease in patients with GO. Large controlled trials are lacking and data can be extracted mainly from small retrospective and some prospective studies, after excluding patients who had received radioiodine for thyrotoxicosis or surgical treatment for GO. In general, more than half of GO patients may show spontaneous improvement in their clinical features, whereas no safe conclusions can be drawn with regard to complete resolution, with percentages ranging from 6 to 58 %.


CONCLUSIONS
The question whether mild GO is a remitting, albeit chronic disease, or even a transient event in the course of Graves' disease, remains currently unanswered.
Department of Endocrinology and Diabetes, Hippokration Hospital of Thessaloniki, Sarantaporou 10, 54640, Thessaloníki, Greece. anagnwstis.pan@yahoo.gr.
P
P
Anagnostis
1st University Department of Ophthalmology, Aristotle University of Thessaloniki, Thessaloníki, Greece.
K
K
Boboridis
Department of Endocrinology and Diabetes, Hippokration Hospital of Thessaloniki, Sarantaporou 10, 54640, Thessaloníki, Greece.
F
F
Adamidou
Department of Endocrinology and Diabetes, Hippokration Hospital of Thessaloniki, Sarantaporou 10, 54640, Thessaloníki, Greece.
M
M
Kita
D002908:Chronic Disease; D049970:Graves Ophthalmopathy / Q000503:physiopathology*; D006801:Humans
Graves’ disease; Graves’ orbitopathy; Natural course
Clin Endocrinol (Oxf). 1987 Jul;27(1):125-33
3652483
Clin Exp Ophthalmol. 2004 Feb;32(1):46-50
14746591
Clin Endocrinol (Oxf). 1995 Jan;42(1):45-50
7889631
J Endocrinol Invest. 2014 Aug;37(8):691-700
24913238
Eur Thyroid J. 2016 Mar;5(1):9-26
27099835
J Clin Endocrinol Metab. 2013 Apr;98(4):1443-9
23408569
CMAJ. 1987 Feb 15;136(4):369-72
3815199
Br Med J. 1977 Jan 29;1(6056):273-5
576414
N Engl J Med. 1992 Jun 25;326(26):1733-8
1489388
Clin Endocrinol (Oxf). 1999 Oct;51(4):503-8
10583319
Eur J Endocrinol. 2002 Jun;146(6):751-7
12039694
Swiss Med Wkly. 2001 Oct 20;131(41-42):603-9
11820071
J Clin Endocrinol Metab. 1969 Jul;29(7):982-4
5819411
Ophthalmology. 1996 Jun;103(6):958-62
8643255
Metabolism. 1957 Jan;6(1):36-48
13386967
Thyroid. 2014 Jan;24(1):60-6
23980907
N Engl J Med. 2011 May 19;364(20):1920-31
21591944
BMJ Case Rep. 2013 Jul 13;2013:null
23853193
J Endocrinol Invest. 2015 Apr;38(4):481-7
25722226